Evidence map›Paper›PMID 32988731›Full record

ArticleJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy2021

Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers.

Tetsuya Suzuki, Kayoko Hayakawa, Akira Ainai, Naoko Iwata-Yoshikawa, Kaori Sano, Noriyo Nagata, Tadaki Suzuki, Yuji Wakimoto, Yutaro Akiyama, Yusuke Miyazato and 13 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04937257 (Comparison of a Virtual Reality Versus an E-Module on Efficacy of Donning and Doffing PPE), which is not on this map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04937257 nacompletednot on this map

Comparison of a Virtual Reality Versus an E-Module on Efficacy of Donning and Doffing PPE: A Randomized Control Trial

TypeinterventionalSponsorMontefiore Medical CenterRan2020 to 2021Enrolled54ConditionsMedical TrainingArmsVirtual Reality, E-module
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. COVID-19 Prevention and Control Measures in Workplace Settings: A Rapid Review and Meta-Analysis.International journal of environmental research and public health · 2021
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Maoto, a traditional herbal medicine, for post-exposure prophylaxis for Japanese healthcare workers exposed to COVID-19: A single center study.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Implementing COVID-19 Simulation Training for Anesthesiology Residents.MedEdPORTAL : the journal of teaching and learning resources · 2022
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 1 country.

Tetsuya SuzukiDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan. Electronic address: tesuzuki@hosp.ncgm.go.jp.
Kayoko HayakawaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Akira AinaiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Naoko Iwata-YoshikawaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Kaori SanoDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Noriyo NagataDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Tadaki SuzukiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Yuji WakimotoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yutaro AkiyamaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yusuke MiyazatoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Keiji NakamuraDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Satoshi IdeDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Hidetoshi NomotoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Takato NakamotoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Masayuki OtaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yuki MoriyamaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Yuko SugikiInfection Control Team, National Center for Global Health and Medicine, Tokyo, Japan; Department of Nursing, National Center for Global Health and Medicine, Tokyo, Japan.
Sho SaitoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Shinichiro MoriokaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Masahiro IshikaneDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Noriko KinoshitaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Satoshi KutsunaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Norio OhmagariDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
National Center for Global Health and Medicine · JPNational Institute of Infectious Diseases · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInformation on the effectiveness of personal protective equipment (PPE) for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among healthcare workers (HCWs), especially among HCWs with frequent contact with patients with SARS-CoV-2, is limited.

methodsWe conducted a prospective cohort study on 49 HCWs who worked in close contact with patients with SARS-CoV-2 infection. HCWs had blood samples taken every 2 weeks to test for SARS-CoV-2 antibodies using two different types of assay.

resultsForty-nine participants (31 nurses, 15 doctors, 3 other workers) were enrolled. In total, 112 blood samples are obtained from participants. The median work days in 2 weeks was 9 (interquartile range (IQR): 5-10) days. In a single work day, 30 of the 49 participants (61.5%) had contact with patients with suspected or conformed SARS-CoV-2 at least 8 times, and approximately 60% of participants had more than 10 min of contact with a single patient. The median self-reported compliance to PPE was 90% (IQR: 80-100%). Seven participants tested positive for SARS-CoV-2 antibody using enzyme-linked immunosorbent assay (ELISA); however, none were seropositive for SARS-CoV-2 neutralizing antibody, so the positive ELISA results were assumed to be false-positive.

conclusionsThe study provides evidence that appropriate PPE is sufficient to prevent infection amongHCWs. It is necessary to establish a system that provides a stable supply of PPE for HCWs to perform their duties.

Indexed as

Health PersonnelPersonal Protective EquipmentAdultAgedAntibodies, ViralBetacoronavirusCoronavirus InfectionsCOVID-19Enzyme-Linked Immunosorbent AssayFemaleHumansInfectious Disease Transmission, Patient-to-ProfessionalMaleMiddle AgedPandemicsPneumonia, ViralAntibodies, ViralCOVID-19Healthcare workersHospital-acquired infectionPersonal protective equipmentSARS-CoV-2

Identifiers

PMID32988731
PMCPMC7480255
OpenAlexW3083777359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.